TPG's Jim Coulter on the business impact of Pfizer's vaccine rollout
Jim Coulter, co-founder and co-CEO of TPG, which oversees $85 billion in assets under management, joined "Squawk Box" on Monday to discuss what he thinks a working vaccine could mean for the markets and investors.
Видео TPG's Jim Coulter on the business impact of Pfizer's vaccine rollout канала CNBC Television
Видео TPG's Jim Coulter on the business impact of Pfizer's vaccine rollout канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Pfizer negotiating with U.S. to provide additional 100 million Covid vaccine doses, CEO saysTech stocks will send the S&P higher through 2021: Kevin O'LearyThe cold chain remains biggest concern for Covid vaccine: Fmr. FDA commissionerJim Cramer on the Pfizer vaccine rollout: 'This is a historic moment'Here's what's different about Apple's chip effortsApple TV+ pulls plug on production about GawkerBillionaire investor Andrew Wilkinson on WeCommerce's trading debutHere's what's driving the IPO volatilityWhat investors should know about how stocks are added to the Nasdaq 100NYT's Jim Stewart: Covid vaccine has me changing my portfolioPfizer-BioNTech Covid vaccine distribution begins around the United StatesAffirm and Roblox delay IPOs until 2021Here's how Oakmark's Bill Nygren is looking for value in the marketElectoral College meets across the country to vote for president and vice presidentWATCH LIVE: Health officials discuss Pfizer Covid vaccine as U.S. begins administering shots — 12/141st COVID-19 vaccine shipments arrive in CanadaFirst Covid vaccines delivered across the U.S. — Here's how distribution is goingHere's how hospitals are preparing for the Covid vaccineWatch the first health workers receive Pfizer's Covid vaccine in New YorkOnline Event: Year-End Reflections on 2020 with Dr. Anthony Fauci